Baxter recalls

Baxter is recalling five surgical table and operating table column models: TruSystem 7500, TruSystem 7000 U, TS7500 MOBIUS, and TruSystem 7500 Hybrid Plus. The main lift may unexpectedly drop to its lowest position during use, and the tabletop could not be raised again after a drop. This has been linked to unexpected wear of the main lift assembly, also called the telescopic spindle. An uncontrolled drop may cause abrupt patient displacement, which could lead to traumatic injury, airway compromise, or surgical complications. Baxter has received three complaints and no patient injuries have been reported.

Serious·FDA·Nov 3, 20265 products

Baxter is recalling two products: the TruSystem 7000 U Operating Table (dV), product code 1723633, and the mobile column TruSystem 7500 U, product code 1730720. The main lift may unexpectedly drop to its lowest position during use, and the tabletop may not be able to be raised again, which could cause abrupt patient displacement during surgery. The notice lists possible serious outcomes including traumatic injury and airway compromise. The products were distributed nationwide, with confirmed distribution in IL, MO and TX.

Serious·FDA·Nov 3, 20262 products

Baxter Healthcare's Likorall overhead patient lifts may experience motor shaft breakage combined with reduced safety system performance, causing the lift strap to lower faster than expected during use. This malfunction could result in patient injury if a significant fall occurs.

Serious·FDA·Oct 21, 2026

Baxter is recalling three PRO+ MRS mattress surface products, 999 units in total, because the product description on the Unique Device Identification (UDI) label contains errors. The mismatched labels could lead to incorrect product identification or selection, potentially resulting in use with an incompatible bed frame. No injuries have been reported.

Moderate·FDA·Sep 30, 20263 products

During manufacturing quality testing, contamination in Baxter's test equipment may have affected the accuracy of nebulizer flow rate measurements on two VOLARA Homecare devices. The company has retrieved the affected units and retested them; both met specifications.

Moderate·FDA·Sep 30, 2026

Baxter Healthcare identified stainless steel particles in certain 2000 mL bags of Dextrose Injection, USP 70%. The contamination affected 606 bags (Lot #Y495066, expiration July 31, 2027) distributed nationwide. No injuries have been reported.

Serious·FDA·Sep 16, 2026

Baxter is recalling two Novum IQ syringe pump models, totaling about 14,605 units. During a Volume/Time (VOT) multi-syringe infusion, a software issue may occur if a syringe runs empty and is replaced while the Volume To Be Infused (VTBI) is still remaining. No injuries have been reported.

Moderate·FDA·Sep 9, 20262 products

Baxter Healthcare Corporation is recalling 0.9% Sodium Chloride Injection USP in 500 mL VIAFLEX plastic containers because some bags contain fiberglass particles. The affected lots are Y495523 and Y495523A, expiring October 31, 2027. No injuries have been reported.

Serious·FDA·Sep 9, 2026

Baxter is recalling 17 intravenous (IV) drug products for manufacturing quality problems, called CGMP deviations, which are lapses in the required production standards. The products include vancomycin, daptomycin, clindamycin, famotidine, dexmedetomidine, vasopressin, pantoprazole, insulin, nicardipine, and amiodarone, plus the brand names Myxredlin, CARDENE IV, and Nexterone. They were distributed nationwide, in Puerto Rico, and in Chile, and no injuries have been reported.

Moderate·FDA·Sep 9, 202617 products

Baxter is recalling one lot of Anticoagulant Sodium Citrate Solution used with apheresis devices due to potential fiberglass particles in the solution. The affected product was distributed to one customer in the United States between July 2 and July 11, 2026. No adverse events have been reported to date.

Moderate·FDA·Aug 26, 2026

Baxter is recalling two lots of 0.9% Sodium Chloride Injection (saline solution) used in hospitals and dialysis centers because fiberglass particles have been found in the solution. The affected lots were distributed to hospitals and medical suppliers in 14 states between July 31 and August 3, 2026. No injuries have been reported so far.

Serious·FDA·Aug 25, 2026

Baxter is recalling one lot of 70% Dextrose Injection used in hospitals and care facilities because stainless steel particles were found in the solution. If given intravenously, these particles could cause blood clots, block blood vessels, or damage organs. No patient injuries have been reported so far.

Serious·FDA·Aug 25, 2026

Baxter Healthcare is recalling certain Duo-Vent solution sets (product code 1C8507) because air bubbles can form in the drip chamber and tubing. Customers reported this happening when a pressure cuff was in use or when the tubing was flushed with the clamp fully open. About 24,528 units were distributed nationwide, and no injuries have been reported.

Serious·FDA·Aug 19, 2026

Baxter Healthcare Corporation is recalling one lot of Cefazolin in Dextrose injection due to the presence of particulate matter in the solution. The affected product is a frozen premix infusion bag used for intravenous antibiotic treatment. This is a Class I recall, the most serious classification.

Serious·FDA·Aug 19, 2026

Baxter is recalling one lot of Cefazolin in Dextrose Injection (a frozen antibiotic infusion bag) because cardboard particles were found in the solution. The affected lot (LD175708, expiring February 14, 2027) was distributed between March and June 2025. No injuries have been reported so far.

Serious·FDA·Jul 24, 2026

The Adapter for Head Positioning (Model 1739994) used with Baxter operating tables may become loose during patient positioning and move unintentionally. This affects 13 units distributed worldwide, primarily in Minnesota, Maryland, Pennsylvania, Canada, and numerous other countries.

Moderate·FDA·Jul 8, 2026

Four Hillrom VOLARA System patient circuit kits are included in this recall. Air and medication can leak from the nebulizer cup during therapy, which can lower a patient's oxygen level and make the treatment less effective. The problem has been linked to the nebulizer cup not being locked properly after medication is added during setup. No injuries have been reported.

Serious·FDA·Jul 8, 20264 products

Baxter Healthcare has issued an urgent correction for the Blue Ventilator Adapter Module used with the Volara Respiratory Therapy system in home care settings. Patients or caregivers may not be aware of risks including dangerously low oxygen levels or lung injury from improper device use.

Serious·FDA·Apr 8, 2026

The Welch Allyn Spot Vision Screener VS100 (software version 3.2.0.1) may display an unintended flickering screen due to a software issue. Flickering lights can trigger seizures in people who are photosensitive.

Moderate·FDA·Mar 25, 2026

Baxter Healthcare released 5 Spectrum IQ infusion pumps (model 3570009) without completing required safety tests, including tests of the occlusion alarm that alerts users to blockages. The pumps were distributed in Ohio. No injuries have been reported.

Moderate·FDA·Feb 25, 2026

Baxter Healthcare's Sterile Water for Irrigation 250 mL bottles may contain small plastic particles that came loose from the bottle rim and entered the solution. This affects lot G171359 with an expiration date of 05/31/2027. No injuries have been reported.

Moderate·FDA·Feb 4, 2026

Baxter Healthcare has recalled certain SIGMA Spectrum infusion pumps (model 35700BAX2) because they may contain defective grease on internal gears. This defective grease does not lubricate properly, which can cause premature wear of the pump mechanism and lead to the pump delivering too much medication or allowing medication to flow freely without stopping.

Serious·FDA·Jan 28, 2026

Replacement bladder kit for the Welch Allyn two-piece reusable blood pressure cuff may contain a Large Adult size bladder rather than a Thigh size bladder in the replacement kits.

FDA·Dec 10, 2025